Literature DB >> 19190998

Delivery of HSF1(+) protein using HIV-1 TAT protein transduction domain.

Yonghui Hou1, Jiangying Zou.   

Abstract

HSF1 is the major transcription factor of HSPs (heat shock proteins) in response to various stresses. Wild type HSF1 (heat shock transcriptional factor 1) is normally inactive, while a constitutively active form of HSF1 (HSF1(+)) can activate downstream HSP expression in the absence of stresses. Here we generated the eukaryotic vectors that expresses HSF1(+) fusion proteins, and found that HSF1(+)-TAT fusion protein was expressed and activated HSP expression. TAT, as a trans-acting factor of HIV-1, has been demonstrated to deliver functional cargo protein into living cells. HSF1(+)-TAT fusion protein was expressed in E. coli, purified, incubated with A549 cells for 8 h, Western blot analysis and luciferase reporter assay showed that HSF1(+) fusion protein was delivered into A549 cells successfully, and the accumulation of HSF1(+)-TAT fusion protein in A549 cells up-regulated HSP70 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190998     DOI: 10.1007/s11033-008-9444-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  35 in total

Review 1.  Protein transduction: unrestricted delivery into all cells?

Authors:  S R Schwarze; K A Hruska; S F Dowdy
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

Review 2.  On mechanisms that control heat shock transcription factor activity in metazoan cells.

Authors:  Richard Voellmy
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

Review 3.  Dominant-positive and dominant-negative heat shock factors.

Authors:  Richard Voellmy
Journal:  Methods       Date:  2004-12-19       Impact factor: 3.608

4.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.

Authors:  H Nagahara; A M Vocero-Akbani; E L Snyder; A Ho; D G Latham; N A Lissy; M Becker-Hapak; S A Ezhevsky; S F Dowdy
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

5.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.

Authors:  M Green; P M Loewenstein
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

6.  Heat-inducible human factor that binds to a human hsp70 promoter.

Authors:  R E Kingston; T J Schuetz; Z Larin
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

7.  The third helix of the Antennapedia homeodomain translocates through biological membranes.

Authors:  D Derossi; A H Joliot; G Chassaing; A Prochiantz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

8.  Intracellular delivery of HSP70 using HIV-1 Tat protein transduction domain.

Authors:  Derek S Wheeler; Katherine E Dunsmore; Hector R Wong
Journal:  Biochem Biophys Res Commun       Date:  2003-01-31       Impact factor: 3.575

9.  Heat shock transcription factor 1 protects cardiomyocytes from ischemia/reperfusion injury.

Authors:  Yunzeng Zou; Weidong Zhu; Masaya Sakamoto; Yingjie Qin; Hiroshi Akazawa; Haruhiro Toko; Miho Mizukami; Norihiko Takeda; Tohru Minamino; Hiroyuki Takano; Toshio Nagai; Akira Nakai; Issei Komuro
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

10.  Multiple layers of regulation of human heat shock transcription factor 1.

Authors:  J Zuo; D Rungger; R Voellmy
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

View more
  4 in total

Review 1.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

Review 2.  Molecular chaperones and co-chaperones in Parkinson disease.

Authors:  Hemi Dimant; Darius Ebrahimi-Fakhari; Pamela J McLean
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

Review 3.  Molecular chaperones as rational drug targets for Parkinson's disease therapeutics.

Authors:  S K Kalia; L V Kalia; P J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

4.  Secretory TAT-peptide-mediated protein transduction of LIF receptor α-chain distal cytoplasmic motifs into human myeloid HL-60 cells.

Authors:  Q Sun; J Xiong; J Lu; S Xu; Y Li; X P Zhong; G K Gao; H Q Liu
Journal:  Braz J Med Biol Res       Date:  2012-06-21       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.